GLP1R Small Molecule Agonists Could Make a Meaningful Difference for Patients
Time: 2:00 pm
day: Conference Day Two
Details:
- Examining the need for differentiated products as more GLP-1s are being developed
- Developing small molecule GLP1R agonists to meet the specific needs of the patients
- Exploring the opportunities for combinations of agonists to gain long-term health benefits
